521 related articles for article (PubMed ID: 19581181)
1. [Post-transplantation malignant tumors and the challenges of immunosuppressive therapy in transplanted patients developing lymphoma. Mycophenolic acid as a possibility].
Végso G
Magy Onkol; 2009 Jun; 53(2):149-56. PubMed ID: 19581181
[TBL] [Abstract][Full Text] [Related]
2. Lymphoma after solid organ transplantation: risk, response to therapy, and survival at a transplantation center.
Knight JS; Tsodikov A; Cibrik DM; Ross CW; Kaminski MS; Blayney DW
J Clin Oncol; 2009 Jul; 27(20):3354-62. PubMed ID: 19451438
[TBL] [Abstract][Full Text] [Related]
3. Mycosis fungoides after solid-organ transplantation: report of 2 new cases.
Rodríguez-Gil Y; Palencia SI; López-Ríos F; Ortiz PL; Rodríguez-Peralto JL
Am J Dermatopathol; 2008 Apr; 30(2):150-5. PubMed ID: 18360119
[TBL] [Abstract][Full Text] [Related]
4. Malignancy after renal transplantation.
Zeier M; Hartschuh W; Wiesel M; Lehnert T; Ritz E
Am J Kidney Dis; 2002 Jan; 39(1):E5. PubMed ID: 11774131
[TBL] [Abstract][Full Text] [Related]
5. Malignancies in renal transplantation: an unmet medical need.
Dantal J; Pohanka E
Nephrol Dial Transplant; 2007 May; 22 Suppl 1():i4-10. PubMed ID: 17456618
[TBL] [Abstract][Full Text] [Related]
6. Urological malignancy after renal transplantation.
Besarani D; Cranston D
BJU Int; 2007 Sep; 100(3):502-5. PubMed ID: 17669141
[TBL] [Abstract][Full Text] [Related]
7. Is there a role for proliferation signal/mTOR inhibitors in the prevention and treatment of de novo malignancies after heart transplantation? Lessons learned from renal transplantation and oncology.
Valantine H
J Heart Lung Transplant; 2007 Jun; 26(6):557-64. PubMed ID: 17543777
[TBL] [Abstract][Full Text] [Related]
8. [Cancer in organ transplanted patients].
Pfeffer PF
Tidsskr Nor Laegeforen; 1999 Oct; 119(25):3792-4. PubMed ID: 10574060
[TBL] [Abstract][Full Text] [Related]
9. [Pro and anti-neoplastic effects of immunosuppressive drug in renal transplantation].
Infante B; Stallone G; Schena A; Maiorano A; Gesualdo L; Schena FP; Grandaliano G
G Ital Nefrol; 2006; 23(4):389-95. PubMed ID: 17063439
[TBL] [Abstract][Full Text] [Related]
10. Minimization of maintenance immunosuppression early after renal transplantation: an interim analysis.
Bemelman FJ; de Maar EF; Press RR; van Kan HJ; ten Berge IJ; Homan van der Heide JJ; de Fijter HW
Transplantation; 2009 Aug; 88(3):421-8. PubMed ID: 19667948
[TBL] [Abstract][Full Text] [Related]
11. Cancers after renal transplantation: multicenter experience.
Harzallah K; Abderrahim E; Chareffedine K; Yeich S; Belhadj R; Skhiri H; Younsi F; Abdallah TB; Abdelletif A; Hachicha J; Hmida J; El May M; Khedr A; Manaa J
Saudi J Kidney Dis Transpl; 2008 Sep; 19(5):825-30. PubMed ID: 18711309
[TBL] [Abstract][Full Text] [Related]
12. [Malignant tumors following renal transplantation].
Végso G; Járay J
Orv Hetil; 2007 Nov; 148(45):2115-23. PubMed ID: 17984022
[TBL] [Abstract][Full Text] [Related]
13. Gynecological issues after organ transplantation.
Kaminski P; Bobrowska K; Pietrzak B; Bablok L; Wielgos M
Neuro Endocrinol Lett; 2008 Dec; 29(6):852-6. PubMed ID: 19112398
[TBL] [Abstract][Full Text] [Related]
14. Study on eight patients with malignant tumors after renal transplantation.
Marubayashi S; Tashiro H; Watanabe H; Fudaba Y; Hayamizu K; Ohdan H; Okimasa S; Katayama K; Itamoto T; Haruta N; Okajima M; Kataoka T; Sugino K; Yahata H; Ishikawa T; Fukuda Y; Dohi K; Asahara T
Hiroshima J Med Sci; 2000 Jun; 49(2):117-20. PubMed ID: 10920578
[TBL] [Abstract][Full Text] [Related]
15. Immunosuppressive therapy does not prevent the occurrence of immunoglobulin E-mediated allergies in children and adolescents with organ transplants.
Dehlink E; Gruber S; Eiwegger T; Gruber D; Mueller T; Huber WD; Klepetko W; Rumpold H; Urbanek R; Szépfalusi Z
Pediatrics; 2006 Sep; 118(3):e764-70. PubMed ID: 16950967
[TBL] [Abstract][Full Text] [Related]
16. Consensus report on therapeutic drug monitoring of mycophenolic acid in solid organ transplantation.
Kuypers DR; Le Meur Y; Cantarovich M; Tredger MJ; Tett SE; Cattaneo D; Tönshoff B; Holt DW; Chapman J; Gelder Tv;
Clin J Am Soc Nephrol; 2010 Feb; 5(2):341-58. PubMed ID: 20056756
[TBL] [Abstract][Full Text] [Related]
17. Toward the definition of immunosuppressive regimens with antitumor activity.
Casadio F; Croci S; D'Errico Grigioni A; Corti B; Grigioni WF; Landuzzi L; Lollini PL
Transplant Proc; 2005 Jun; 37(5):2144-7. PubMed ID: 15964362
[TBL] [Abstract][Full Text] [Related]
18. Varicella zoster virus-associated disease in adult kidney transplant recipients: incidence and risk-factor analysis.
Arness T; Pedersen R; Dierkhising R; Kremers W; Patel R
Transpl Infect Dis; 2008 Jul; 10(4):260-8. PubMed ID: 18086277
[TBL] [Abstract][Full Text] [Related]
19. Post-transplant lymphomas: a 20-year epidemiologic, clinical and pathologic study in a single center.
Domingo-Domènech E; de Sanjosé S; González-Barca E; Romagosa V; Domingo-Clarós A; Gil-Vernet S; Figueras J; Manito N; Otón B; Petit J; Grañena A; Fernández de Sevilla A
Haematologica; 2001 Jul; 86(7):715-21. PubMed ID: 11454526
[TBL] [Abstract][Full Text] [Related]
20. Immunosuppression in renal transplantation: some aspects for the modern era.
Chadban S; Morris R; Hirsch HH; Bunnapradist S; Arns W; Budde K
Transplant Rev (Orlando); 2008 Oct; 22(4):241-51. PubMed ID: 18657962
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
